Low total testosterone levels are associated with the metabolic syndrome in elderly men: The role of body weight, lip-ids, insulin resistance, and inflammation; the Ikaria study

Review of Diabetic Studies

Volumn 10, Issue 1, 2013, Pages 27-38

  Chrysohoou, Christina ^a   Panagiotakos, Demosthenes ^b   Pitsavos, Christos ^a   Siasos, Gerasimos ^a   Oikonomou, Evangelos ^a   Varlas, John ^c   Patialakas, Athanasios ^a   Lazaros, George ^a   Psaltopoulou, Theodora ^a   Zaromitidou, Marina ^a   Kourkouti, Polina ^a   Tousoulis, Dimitris ^a   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HAROKOPIO UNIVERSITY   (Greece)

^c Medicon SA   (Greece)

Author keywords

Body mass; C reactive protein; Cardiovascular disease; Elderly; Inflammation; Insulin resistance; Lipids; Metabolic syndrome; Testosterone; Type 2 diabetes

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TESTOSTERONE;

AGED; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; ENZYME IMMUNOASSAY; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; HYPERCHOLESTEROLEMIA; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL ASSESSMENT; PHYSICAL ACTIVITY; PREVALENCE; SMOKING; WAIST CIRCUMFERENCE;

AGED; AGED, 80 AND OVER; BODY WEIGHT; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; FEMALE; GREECE; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; METABOLIC SYNDROME X; TESTOSTERONE; TRIGLYCERIDES;

EID: 84878174603     PISSN: 16136071     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/RDS.2013.10.27     Document Type: Article

References (42)

1. Veronica G, Esther RR. Aging, metabolic syndrome and the heart. Aging Dis 2012. 3:269-279.
2. Eichholzer M, Barbir A, Basaria S, Dobs AS, Feinleib M, Guallar E, Menke A, Nelson WG, Rifai N, Platz EA, Rohrmann S. Serum sex steroid hormones and frailty in older American men of the Third National Health and Nutrition Examination Survey (NHANES III). Aging Male 2012. 15:208-215.
3. Tyrovolas S, Chalkias C, Morena M, Tsiligianni I, Zeimbekis A, Gotsis E, Metallinos G, Bountziouka V, Polychronopoulos E, Lionis C, Panagiotakos D. Health care access and prevalence of the metabolic syndrome among elders living in high-altitude areas of the Mediterranean islands: the MEDIS study. Rev Diabet Stud 2011. 8:468-476.
4. Taskinen MR. Is metabolic syndrome the main threat to human health in the twenty-first century? Arterioscler Thromb Vasc Biol 2007. 27:2275.
5. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005. 112:2735-2752.
6. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005. 28:2745-2749.
7. Tyrovolas S, Zeimbekis A, Bountziouka V, Voutsa K, Pounis G, Papoutsou S, Metallinos G, Ladoukaki E, Polychronopoulos E, Lionis C, Panagiotakos DB. Factors associated with the prevalence of diabetes mellitus among elderly men and women living in Mediterranean Islands: The MEDIS Study. Rev Diabet Stud 2009. 6(1):54-63.
8. Araujo AB, Wittert GA. Endocrinology of the aging male. Best Pract Res Clin Endocrinol Metab 2011. 25:303-319.
9. De Pergola G. The adipose tissue metabolism: role of testosterone and dehydroepiandrosterone. Int J Obes Relat Metab Disord 2000. 24:S59-S63.
10. Haring R, Volzke H, Steveling A, Krebs A, Felix SB, Schofl C, Dorr M, Nauck M, Wallaschofski H. Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79. Eur Heart J 2010. 31:1494-1501.
11. Brand JS, van der Tweel I, Grobbee DE, Emmelot-Vonk MH, van der Schouw YT. Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies. Int J Epidemiol 2011. 40:189-207.
12. Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005. 26:833-876.
13. Stefanadis CI. Unveiling the secrets of longevity: the Ikaria study. Hellenic J Cardiol 2011. 52:479-480.
14. The Blue Zones, August 2012, http://www.bluezones.com/about-the-blue-zones-community.
15. Chrysohoou C, Skoumas J, Pitsavos C, Masoura C, Siasos G, Galiatsatos N, Psaltopoulou T, Mylonakis C, Margazas A, Kyvelou S, Stefanadis C. Long-term adherence to the Mediterranean diet reduces the prevalence of hyperuricaemia in elderly individuals, without known cardiovascular disease: the Ikaria study. Maturitas 2011. 70:58-64.
16. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001. 285:2486-2497.
17. Demetriou JA. Testosterone in: Pesce AJ, Kaplan LA (editors). Methods in clinical chemistry. St Louis, The C. V. Mosby company, 1987.
18. Dati F, Schumann G, Thomas L, Aguzzi F, Baudner S, Bienvenu J, Blaabjerg O, Blirup-Jensen S, Carlström A, Petersen PH, Johnson AM, Milford-Ward A, Ritchie RF, Svendsen PJ, Whicher J. Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists. Eur J Clin Chem Clin Biochem 1996. 34:517-520.
19. Schnell O, Otter W, Standl E. The Munich Myocardial Infarction Registry: translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice. Diabetes Care 2009. 32:S326-330.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985. 28:412-419.
21. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003. 35:1381-1395.
22. Tyrovolas S, Pounis G, Bountziouka V, Poly-chronopoulos E, Panagiotakos DB. Repeatability and validation of a short, semi-quantitative food frequency questionnaire designed for older adults living in Mediterranean areas: the MEDIS-FFQ. J Nutr Elder 2010. 29:311-324.
23. Panagiotakos DB, Pitsavos C, Arvaniti F, Stefanadis C. Adherence to the Mediterranean food pattern predicts the prevalence of hypertension, hypercholesterolemia, diabetes and obesity, among healthy adults; the accuracy of the MedDietScore. Prev Med 2007. 44:335-340.
24. Panagiotakos DB, Pitsavos C, Das UN, Skoumas Y, Stefanadis C. The implications of anthropometric, inflammatory and glycaemic control indices in the epidemiology of the metabolic syndrome given by different definitions: a classification analysis. Diabetes Obes Metab 2007. 9:660-668.
25. Denys K, Cankurtaran M, Janssens W, Petrovic M. Metabolic syndrome in the elderly: an overview of the evidence. Acta Clin Belg 2009. 64:23-34.
26. Rathmann W, Haastert B, Icks A, Giani G, Holle R, Koenig W, Lowel H, Meisinger C. Prevalence of the metabolic syndrome in the elderly population according to IDF, WHO, and NCEP definitions and associations with C-reactive protein: the KORA Survey 2000. Diabetes Care 2006. 29:461.
27. Saukkonen T, Jokelainen J, Timonen M, Cederberg H, Laakso M, Harkonen P, Keinanen-Kiukaanniemi S, Rajala U. Prevalence of metabolic syndrome components among the elderly using three different definitions: a cohort study in Finland. Scand J Prim Health Care 2012. 30:29-34.
28. Hyde Z, Norman PE, Flicker L, Hankey GJ, Almeida OP, McCaul KA, Chubb SA, Yeap BB. Low free testosterone predicts mortality from cardiovascular disease but not other causes: the Health in Men Study. J Clin Endocrinol Metab 2012. 97:179-189.
29. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 1986. 111:383-390.
30. Ruige JB, Mahmoud AM, De Bacquer D, Kaufman JM. Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis. Heart 2011. 97:870-875.
31. Akishita M, Fukai S, Hashimoto M, Kameyama Y, Nomura K, Nakamura T, Ogawa S, Iijima K, Eto M, Ouchi Y. Association of low testosterone with metabolic syndrome and its components in middle-aged Japanese men. Hypertens Res 2010. 33:587-591.
32. Blouin K, Despres JP, Couillard C, Tremblay A, Prud'homme D, Bouchard C, Tchernof A. Contribution of age and declining androgen levels to features of the metabolic syndrome in men. Metabolism 2005. 54:1034-1040.
33. Tsai EC, Matsumoto AM, Fujimoto WY, Boyko EJ. Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat. Diabetes Care 2004. 27:861-868.
34. Guzzardi MA, Iozzo P. Fatty heart, cardiac damage, and inflammation. Rev Diabet Stud 2011. 8:403-417.
35. Maggio M, Basaria S, Ble A, Lauretani F, Bandinelli S, Ceda GP, Valenti G, Ling SM, Craig CL, Marshall AL, et al. Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men. J Clin Endocrinol Metab 2006. 91: 345-347.
36. Kalinchenko SY, Tishova YA, Mskhalaya GJ, Gooren LJ, Giltay EJ, Saad F. Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study. Clin En-docrinol (Oxf) 2010. 73:602-612.
37. Das UN. Is metabolic syndrome X an inflammatory condition? Exp Biol Med (Maywood) 2002. 227:989-997.
38. Lyon CJ, Law RE, Hsueh WA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 2003. 144:2195-2200.
39. De Maddalena C, Vodo S, Petroni A, Aloisi AM. Impact of testosterone on body fat composition. J Cell Physiol 2012. 227:3744-3748.
40. Cohen PG. The hypogonadal-obesity cycle: role of aroma-tase in modulating the testosterone-estradiol shunt-a major factor in the genesis of morbid obesity. Med Hypotheses 1999. 52:49-51.
41. Dhindsa S, Furlanetto R, Vora M, Ghanim H, Chaudhuri A, Dandona P. Low estradiol concentrations in men with subnormal testosterone concentrations and type 2 diabetes. Diabetes Care 2011. 34:1854-1859.
42. Bhasin S, Jasjua GK, Pencina M, D'Agostino R Sr, Coviello AD, Vasan RS, Travison TG. Sex hormone-binding globulin, but not testosterone, is associated prospec-tively and independently with incident metabolic syndrome in men: the Framingham heart study. Diabetes Care 2011. 34:2464-2470.